Categories: Health Care, Life Sciences, Pharma, Biotech, Public Sector & Regulatory, Publications & Presentations
Share:
1 May 2016 
Kesselring Felix/Kohler Stefan, Is clampdown on Swiss stem cell therapies justified?, in: China Business Law Journal Volume 7 Issue 4, April 2016, S. 78 f.